Brief: Lilly To Acquire Adverum Biotechnologies
24/10/2025 13:42
Oct 24 (Reuters) - Adverum Biotechnologies Inc ADVM.O: LILLY TO ACQUIRE ADVERUM BIOTECHNOLOGIES ELI LILLY - TO BUY ADVERUM SHARES FOR $3.56 PLUS CVR UP TO $8.91 ELI LILLY - ADVERUM ENTERS $65 MILLION PROMISSORY NOTE WITH LILLY FOR IXO-VEC TRIALS Source text: ID:nPnbSXZ4ma Further company coverage: ADVM.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adverum Biotechnologies
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Adverum Reminds Stockholders To Tender Their Shares Into The Offer By Lilly
Brief: Adverum Biotechnologies Inc - Are-Nc Region No. 21 Llc Terminates Certain Lease Agreement With Adverum Biotechnologies - SEC Filing
Eli Lilly bets on eye care with buyout of gene therapy developer Adverum (updated)